Document:

THESE  SECURITIES  HAVE  NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS
AMENDED,  OR ANY STATE SECURITIES LAWS.  THEY MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED,  OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATE-MENT
RELATED  THERETO  OR  AN  OPINION  OF  COUNSEL  (WHICH  MAY  BE COMPANY COUNSEL)
REASONABLY  SATISFACTORY  TO  THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES
LAWS.

                                WARRANT AGREEMENT

                    TO PURCHASE SHARES OF THE COMMON STOCK OF

                          WORLDWIDE MEDICAL CORPORATION

              DATED AS OF SEPTEMBER 18, 2002 (THE "EFFECTIVE DATE")

     WHEREAS,  Worldwide  Medical  Corporation,  a  Delaware  corporation  (the
"Company"),  has  entered  into  a Loan Agreement dated as of September 18, 2002
(the "Loan Agreement") with Ziegler Healthcare Fund I, LP (the "Warrantholder").

     WHEREAS,  the  Company  desires  to  grant  to  the  Warrantholder,  in
consideration for entering into the Loan Agreement, the right to purchase shares
of  the  Company's  Common  Stock;

     NOW,  THEREFORE,  in  consideration  of  the  Warrantholder  executing  and
delivering  such  Loan  Agreement  and  in consideration of mutual covenants and
agreements  contained  herein,  the  Company and Warrantholder agree as follows:

1.     GRANT  OF  THE  RIGHT  TO  PURCHASE  PREFERRED  STOCK.
       -----------------------------------------------------

     The  Company  hereby  grants to the Warrantholder, and the Warrantholder is
entitled, upon the terms and subject to the conditions hereinafter set forth, to
subscribe  to  and  purchase,  from  the  Company,  2,598,053  fully  paid  and
non-assessable  shares  of  the  Company's  Common  Stock  ("Common Stock") at a
purchase  price of $0.10 per share (the "Exercise Price"), at such time and from
time  to  time thereafter, once the fair market value of the Common Stock of the
Company  (as  determined  below),  shall  equal  or  exceed $0.20 per share (the
"Strike  Price").  The  number  and purchase price of such shares are subject to
adjustment  as  provided  in  Section  8 hereof.  As used herein, "Common Stock"
                                                                   ------------
shall  mean  the  Company's  Common Stock, and any other stock into or for which
such  Common  Stock  may  hereafter  be  converted  or  exchanged.

<PAGE>

2.     TERM  OF  THE  WARRANT  AGREEMENT.
       ---------------------------------

     Except as otherwise provided for herein, the term of this Warrant Agreement
shall  commence  on  the Effective Date and shall be exercisable for a period of
five (5) years following the Effective Date.  The right to purchase Common Stock
as  granted  herein shall commence one year from the Effective Date and shall be
exercisable  for  a  period  of  five  (5)  years  following the Effective Date.

3.     EXERCISE  OF  THE  PURCHASE  RIGHTS.
       -----------------------------------

     The  purchase rights set forth in this Warrant Agreement are exercisable by
the  Warrantholder,  in  whole  or  in  part, at any time, or from time to time,
commencing  one  year  from  the  Effective  Date  and  thereafter  prior to the
expiration  of  the  term  set  forth  in  Section  2 above, by tendering to the
Company,  at  its  principal  office,  a notice of exercise in the form attached
hereto  as  Exhibit  I  (the "Notice of Exercise"), duly completed and executed.
Promptly  upon receipt of the Notice of Exercise and the payment of the purchase
price  in  accordance with the terms set forth below, and in no event later than
twenty-one  (21) days thereafter, the Company shall issue to the Warrantholder a
certificate for the number of shares of Common Stock purchased and shall execute
the  acknowledgment  of  exercise in the form attached hereto as Exhibit II (the
"Acknowledgment  of  Exercise")  indicating  the  number  of shares which remain
subject  to  future  purchases,  if  any.

     The  Exercise  Price may be paid at the Warrantholder's election either (i)
by  cash  or  check,  or  (ii)  by  surrender  of  Warrants  ("Net Issuance") as
determined  below.  If  the  Warrantholder  elects  the Net Issuance method, the
Company  will  issue  Common  Stock  in  accordance  with the following formula:

               X  =  Y(A-B)
                     ------
                        A

     Where:     X =     the number of shares of Common Stock to be issued to the
                        Warrantholder.

                Y =     the number of  shares  of  Common  Stock requested to be
                        exercised under  this  Warrant  Agreement.

                A =     the fair market value of  one (1) share of Common Stock.

                B =     the  Exercise  Price.

     For  purposes of the above calculation, current fair market value of Common
Stock  shall  mean  with  respect  to  each  share  of  Common  Stock:

          (i)     if  the  Company's  Common  Stock  is  listed  listed  on  any
securities  exchange  or  quoted  in  the  NASDAQ System or the over-the-counter
market:

<PAGE>

               (a)     if traded on a securities exchange, the fair market value
shall  be  deemed  to  be  the average of the closing prices over a five (5) day
period  ending  three  days  before the day the current fair market value of the
securities  is  being  determined;  or

               (b)     if  actively  traded  over-the-counter,  the  fair market
value  shall  be  deemed  to  be the average of the closing bid and asked prices
quoted  on  the  NASDAQ  system (or similar system) over the five (5) day period
ending three days before the day the current fair market value of the securities
is  being  determined.

          (iii)     if  at  any  time  the  Common  Stock  is  not listed on any
securities  exchange  or  quoted  in  the  NASDAQ System or the over-the-counter
market, the current fair market value of Common Stock shall be the highest price
per  share  which  the  Company could obtain from a willing buyer (not a current
employee  or  director)  for  shares  of  Common Stock sold by the Company, from
authorized  but  unissued  shares,  as  determined in good faith by its Board of
Directors,  unless  the Company shall become subject to a merger, acquisition or
other consolidation pursuant to which the Company is not the surviving party, in
which case the fair market value of Common Stock shall be deemed to be the value
received  by  the  holders  of the Company's Common Stock on a common equivalent
basis  pursuant  to  such  merger  or  acquisition.

     Upon  partial  exercise  by  either cash or Net Issuance, the Company shall
promptly issue an amended Warrant Agreement representing the remaining number of
shares  purchasable  hereunder.  All  other terms and conditions of such amended
Warrant  Agreement  shall be identical to those contained herein, including, but
not  limited  to  the  Effective  Date  hereof.

4.     RESERVATION  OF  SHARES.
       -----------------------

     (a)     Authorization  and  Reservation of Shares.  During the term of this
             -----------------------------------------
Warrant  Agreement, the Company will at all times have authorized and reserved a
sufficient  number  of shares of its Common Stock to provide for the exercise of
the  rights  to  purchase  Common  Stock  as  provided  for  herein.

     (b)     Registration or Listing.  If any shares of Common Stock required to
             -----------------------
be  reserved hereunder require registration with or approval of any governmental
authority  under any Federal or State law (other than any registration under the
Securities  Act  of  1933,  as  amended  ("1933 Act"), as then in effect, or any
similar  Federal statute then enforced, or any state securities law, required by
reason  of any transfer involved in such conversion), or listing on any domestic
securities exchange, before such shares may be issued as required hereunder upon
conversion,  the  Company will, at its expense and as expeditiously as possible,
use  its  best  efforts  to  cause  such shares to be duly registered, listed or
approved  for  listing on such domestic securities exchange, as the case may be.

<PAGE>

5.     NO  FRACTIONAL  SHARES  OR  SCRIP.
       ---------------------------------

     No  fractional  shares  or  scrip  representing  fractional shares shall be
issued  upon  the exercise of the Warrant, but in lieu of such fractional shares
the  Company  shall  make a cash payment therefor upon the basis of the Exercise
Price  then  in  effect.

6.     NO  RIGHTS  AS  SHAREHOLDER.
       ---------------------------

     This  Warrant  Agreement  does  not entitle the Warrantholder to any voting
rights  or other rights as a shareholder of the Company prior to the exercise of
the  Warrant.

7.     WARRANTHOLDER  REGISTRY.
       -----------------------

     The  Company  shall maintain a registry showing the name and address of the
registered  holder  of  this  Warrant  Agreement.

8.     ADJUSTMENT  RIGHTS.
       ------------------

     The  purchase  price  per  share  and  the number of shares of Common Stock
purchasable  hereunder  are  subject  to  adjustment,  as  follows:

     (a)     Merger and Sale of Assets.  If at any time there shall be a capital
             -------------------------
reorganization  of  the shares of the Company's stock (other than a combination,
reclassification,  exchange  or  subdivision  of  shares  otherwise provided for
herein),  or  a  merger  or  consolidation  of  the Company with or into another
corporation whether or not the Company is the surviving corporation, or the sale
of  all or substantially all of the Company's properties and assets to any other
person  (hereinafter  referred  to as a "Merger Event"), then, as a part of such
Merger  Event,  lawful  provision  shall be made so that the Warrantholder shall
thereafter  be  entitled to receive, upon exercise of the Warrant, the number of
shares  of  Common  Stock  or  other  securities  of  the  successor corporation
resulting  from  such Merger Event, equivalent in value to that which would have
been  issuable  if Warrantholder had exercised this Warrant immediately prior to
the  Merger  Event.  In  any such case, appropriate adjustment (as determined in
good faith by the Company's Board of Directors) shall be made in the application
of  the  provisions  of  this  Warrant  Agreement with respect to the rights and
interest  of  the  Warrantholder  after  the  Merger  Event  to the end that the
provisions  of  this  Warrant  Agreement  (including adjustments of the Exercise
Price  and  number of shares of Common Stock purchasable) shall be applicable to
the  greatest  extent  possible.

     (b)     Reclassification  of  Shares.  If the Company at any time shall, by
             ----------------------------
combination,  reclassification,  exchange  or  subdivision  of  securities  or
otherwise,  change  any of the securities as to which purchase rights under this
Warrant Agreement exist into the same or a different number of securities of any
other  class  or  classes, this Warrant Agreement shall thereafter represent the
right  to acquire such number and kind of securities as would have been issuable
as  the  result of such change with respect to the securities which were subject
to  the  purchase  rights under this Warrant Agreement immediately prior to such
combination,  reclas-sification,  exchange,  subdivision  or  other  change.

<PAGE>

     (c)     Subdivision  or  Combination of Shares.  If the Company at any time
             --------------------------------------
shall  combine  or  subdivide  its  Common  Stock,  the  Exercise Price shall be
proportionately  decreased  in  the  case  of  a subdivision, or proportionately
increased  in  the  case  of  a  combination.

     (d)     Stock  Dividends.  If  the Company at any time shall pay a dividend
             ----------------
payable in, or make any other distribution (except any distribution specifically
provided  for  in  the foregoing subsections (a) or (b)) of the Company's stock,
then  the  Exercise  Price  shall be adjusted, from and after the record date of
such  dividend  or  distribution,  to  that  price determined by multiplying the
Exercise Price in effect immediately prior to such record date by a fraction (i)
the  numerator of which shall be the total number of all shares of the Company's
stock  outstanding  immediately prior to such dividend or distribution, and (ii)
the  denominator  of  which  shall  be  the  total  number  of all shares of the
Company's  stock  outstanding  immediately  after such dividend or distribution.
The  Warrantholder  shall  thereafter  be  entitled to purchase, at the Exercise
Price  resulting  from  such  adjustment,  the  number of shares of Common Stock
(calculated  to  the  nearest  whole share) obtained by multiplying the Exercise
Price  in effect immediately prior to such adjustment by the number of shares of
Common  Stock  issuable  upon  the  exercise  hereof  immediately  prior to such
adjustment and dividing the product thereof by the Exercise Price resulting from
such  adjustment.

     (e)     Anti-dilution  Rights.
             ---------------------

          (i)  If,  during  the term of the Warrant, the Company shall issue any
     shares of Common Stock or Common Stock Equivalents (as defined herein), the
     number  of  shares  exercisable  hereunder  shall  be  increased  (with  no
     adjustment  in  Applicable  Exercise Price, except as stated below) so that
     the  ratio  of the number of shares issuable to the Warrantholder as of the
     Effective  Date,  to  the  total number of shares of Common Stock or Common
     Stock  Equivalents  outstanding  as  of the Effective Date remains the same
     after  such  issuance, subject to the following adjustments in the Exercise
     Price.

          (ii)  If  the  Company shall, during the term of the Warrant, issue or
     sell  shares  of its Common Stock (or Common Stock Equivalents, as provided
     herein)  at  a  price  per  share equal to or greater than $0.25 per share,
     subject  to  any  subsequent  adjustment  of  an Extraordinary Common Stock
     Event,  as defined below), the number of shares issuable hereunder shall be
     increased  as  provided  in  Subsection  8(e)(i),  above,  without  further
     adjustment  in  the  Applicable  Exercise  Price.

          (iii)  If  the Company shall, during the term of the Warrant, issue or
     sell  shares  of its Common Stock (or Common Stock Equivalents, as provided
     herein) at a price per share that is less than $0.25 per share, but greater
     than  the  "Applicable  Exercise  Price",  as  defined below, then: (a) the
     number  of  shares  issuable  hereunder  shall be increased as provided, in
     subparagraph  (i),  above;  and  (b) the Applicable Exercise Price shall be
     adjusted  down so that the ratio of the Applicable Exercise Price to $0.25,
     shall  be  the  same  as the ratio between the adjusted Applicable Exercise
     Price  and  the  price per share at which such new issuance is consummated.

<PAGE>

          (iv)  If  the  Company shall, during the term of the Warrant, issue or
     sell  shares  of its Common Stock (or Common Stock Equivalents, as provided
     herein)  without  consideration  or  at  a  price  per  share less than the
     Applicable  Exercise  Price in effect immediately prior to such issuance or
     sale,  then  in each such case: (a) the number of shares issuable hereunder
     shall  be  increased  as provided, in subparagraph (i), above; and (b) such
     Applicable  Exercise  Price  upon  each  such  issuance  or sale, except as
     hereinafter  provided,  shall  be  lowered  so  as to be equal to an amount
     determined  by  multiplying  such  Applicable Exercise Price by a fraction:

          the  numerator  of  which  shall be (a) the number of shares of Common
          Stock outstanding immediately prior to the issuance of such additional
          shares  of  Common  Stock or Common Stock Equivalents (calculated on a
          fully-diluted  basis  assuming  the  exercise  or  conversion  of  all
          presently exercisable options, warrants, purchase right or convertible
          securities),  plus  (b) the number of shares of Common Stock which the
          net  aggregate  consideration, if any, received by the Company for the
          total number of such additional shares of Common Stock or Common Stock
          Equivalents  so issued would purchase at the Applicable Exercise Price
          in  effect  immediately  prior  to  such  issuance,  and

          the  denominator  of which shall be (a) the number of shares of Common
          Stock outstanding immediately prior to the issuance of such additional
          shares  of  Common  Stock or Common Stock Equivalents (calculated on a
          fully-diluted  basis  assuming  the  exercise  or  conversion  of  all
          presently exercisable options, warrants, purchase right or convertible
          securities),  plus  (b) the number of such additional shares of Common
          Stock  or  Common  Stock  Equivalents  so  issued.

          (v)  For  the  purposes  of  this Subsection 8(e), the issuance of any
     warrants,  options,  subscription or purchase rights with respect to shares
     of  Common  Stock  and  the  issuance of any securities convertible into or
     exchangeable  for  shares of Common Stock, or the issuance of any warrants,
     options,  subscription  or purchase rights with respect to such convertible
     or  exchangeable  securities  (collectively,  "Common  Stock Equivalents"),
     shall  be  deemed  an  issuance  of  Common  Stock  with  respect  to  the
     determination of dilution hereunder, if the Net Consideration Per Share (as
     hereinafter  determined)  which  may  be  received  by the Company for such
     Common  Stock shall be less than the Applicable Exercise Price in effect at
     the  time  of  such  issuance.  Any obligation, agreement or undertaking to
     issue Common Stock Equivalents at any time in the future shall be deemed to
     be  an  issuance  at  the time such obligation, agreement or undertaking is
     made  or  arises.  No  adjustment of the Applicable Exercise Price shall be
     made, under this Subsection 8(e), upon the issuance of any shares of Common
     Stock  which are issued pursuant to the exercise, conversion or exchange of
     any  Common  Stock Equivalents if any adjustment shall previously have been
     made  upon  the  issuance  of  any  such  Common Stock Equivalents as above
     provided.

<PAGE>

          (vi)  Should  the Net Consideration Per Share of any such Common Stock
     Equivalents be decreased from time to time, then, upon the effectiveness of
     each  such  change,  the Applicable Exercise Price will be that which would
     have  been  obtained (1) had the adjustments made upon the issuance of such
     Common  Stock  Equivalents  been  made  upon  the  basis  of the actual Net
     Consideration  Per  Share  of  such securities, and (2) had the adjustments
     made  to  the  Applicable Exercise Price since the date of issuance of such
     Common  Stock  Equivalents  been  made to such Applicable Exercise Price as
     adjusted  pursuant  to  clause  (i) above. Any adjustment of the Applicable
     Exercise Price with respect to this paragraph which relates to Common Stock
     or  Common  Stock  Equivalents shall be disregarded if, as, and when all of
     such  Common  Stock  or  Common  Stock  Equivalents expire or are cancelled
     without  being  exercised, or are repurchased by the Corporation at a price
     per  share  at  or  less  than  the  original  purchase  price, so that the
     Applicable  Exercise  Price  for such stock effective immediately upon such
     cancellation  or expiration shall be equal to the Applicable Exercise Price
     in  effect  at  the time of the issuance of the expired or cancelled Common
     Stock Equivalents, with such additional adjustments as would have been made
     to  the Applicable Exercise Price had the expired or cancelled Common Stock
     Equivalents  not  been  issued.

          (vii) For purposes of this Subsection 8(e), the "Net Consideration Per
     Share" which may be received by the Company shall be determined as follows:
     (a)  the  "Net  Consideration Per Share" shall mean the amount equal to the
     total  amount  of  consideration,  if  any, received by the Company for the
     issuance  of  such  Common  Stock  Equivalents,  plus the minimum amount of
     consideration,  if any, payable to the Company upon exercise, or conversion
     or  exchange  thereof,  divided by the aggregate number of shares of Common
     Stock  that  would  be  issued  if  all  such Common Stock Equivalents were
     exercised,  exchanged  or  converted;  and  (b)  the "Net Consideration Per
     Share"  which  may  be  received by the Company shall be determined in each
     instance  as  of  the  date of issuance of Common Stock Equivalents without
     giving  effect  to  any  possible  future  upward price adjustments or rate
     adjustments  which  may  be  applicable  with  respect to such Common Stock
     Equivalents.

          (viii)  For  purposes of this Subsection 8(e), if a part or all of the
     consideration  received  by  the Company in connection with the issuance of
     shares  of  the  Common  Stock  or  the  issuance  of any of the securities
     described  in  this  Subsection 8(e), consists of property other than cash,
     such  consideration  shall  be  deemed  to  have  a fair market value as is
     reasonably  determined  in  good  faith  by  the  Board of Directors of the
     Company.  In  the  event  of  any dispute between the Warrantholder and the
     Company  regarding the determination of fair market value, at the option of
     the Warrantholder, the Company shall engage a consulting firm or investment
     banking  firm  selected  jointly  by  the  Company and the Warrantholder to
     prepare  an independent appraisal of the fair market value of such property
     to  be  distributed.  The  expenses of such appraisal shall be borne by the
     Company.

<PAGE>

          (ix)     This Subsection 8(e) shall not apply with respect to: (a) the
issuance  and  sale of Common Stock or options to acquire common stock issued to
employees  of  the  Company,  not  in  excess of 500,000 shares of Common Stock,
except  if  such  stock  is  issued  at  a  price per share less than $0.20; (b)
securities  issued  in  connection  with an acquisition of another entity by the
Company;  or  (c)  the  issuance  of  Common Stock upon exercise of warrants and
options  existing  as  of  the  effective  date  of  this  Agreement.

          (x)     Upon  the happening of an Extraordinary Common Stock Event (as
hereinafter  defined),  the  Applicable Exercise Price (and all other conversion
values  set  forth  in  Subsection  8(e)  above)  shall, simultaneously with the
happening  of  such Extraordinary Common Stock Event, be adjusted by multiplying
the Applicable Exercise Price by a fraction, the numerator of which shall be the
number  of  shares  of  Common  Stock  outstanding  immediately  prior  to  such
Extraordinary  Common  Stock  Event  and  the  denominator of which shall be the
number  of  shares  of  Common  Stock  outstanding  immediately  after  such
Extraordinary  Common  Stock Event, and the product so obtained shall thereafter
be  the  Applicable  Exercise  Price.  The  Applicable  Exercise  Price,  as  so
adjusted,  shall  be  readjusted  in  the  same manner upon the happening of any
successive  Extraordinary  Common  Stock  Event  or  Events.

          (xi)    An  "Extraordinary  Common  Stock  Event"  shall  mean (a) the
issuance  of  additional  shares  of  Common  Stock  as  a  dividend  or  other
distribution  on  outstanding  shares  of  Common  Stock,  (b)  a subdivision of
outstanding  shares  of  Common  Stock into a greater number of shares of Common
Stock,  or  (c)  a  combination  or reverse stock split of outstanding shares of
Common  Stock  into  a  smaller  number  of  shares  of  the  Common  Stock.

          (xii)   For  purposes  of this Subsection 8(e), the initial Applicable
Exercise Price for exercise of this Warrant shall be $0.10 per share, subject to
any  subsequent  adjustment  as  provided  in  this  Subsection  8(e).

     (f)     Notice  of  Adjustments.  If:  (i)  the  Company  shall declare any
             -----------------------
dividend  or  distribution  upon  its stock, whether in cash, property, stock or
other  securities;  (ii) the Company shall offer for subscription prorata to the
holders  of  any  class  of its Common or other convertible stock any additional
shares  of  stock  of any class or other rights; (iii) there shall be any Merger
Event;  or (iv) there shall be any voluntary dissolution, liquidation or winding
up  of  the Company; then, in connection with each such event, the Company shall
send  to  the Warrantholder: (A) at least twenty (20) days' prior written notice
of  the  date on which the books of the Company shall close or a record shall be
taken  for such dividend, distribution, subscription rights (specifying the date
on  which  the  holders  of  Common  Stock  shall  be  entitled  thereto) or for
determining  rights  to  vote  in  respect  of  such  Merger Event, dissolution,
liquidation  or  winding  up;  and  (B)  in  the  case of any such Merger Event,
dissolution, liquidation or winding up, at least twenty (20) days' prior written
notice  of  the  date when the same shall take place (and specifying the date on
which  the  holders  of  Common Stock shall be entitled to exchange their Common
Stock  for  securities  or  other  property  deliverable upon such Merger Event,
dissolution,  liquidation  or  winding  up).

<PAGE>

     Each  such  written  notice  shall set forth, in reasonable detail, (i) the
event  requiring  the  adjustment,  (ii) the amount of the adjustment, (iii) the
method by which such adjustment was calculated, (iv) the Exercise Price, and (v)
the  number  of shares subject to purchase hereunder after giving effect to such
adjustment,  and  shall be given by first class mail, postage prepaid, addressed
to  the  Warrantholder,  at  the  address  as shown on the books of the Company.

     (g)     Timely  Notice.  Failure  to timely provide such notice required by
             --------------
subsection  (f)  above  shall entitle Warrantholder to retain the benefit of the
applicable  notice  period notwithstanding anything to the contrary contained in
any insufficient notice received by Warrantholder. The notice period shall begin
on  the date Warrantholder actually receives a written notice containing all the
information  specified  above.

9.     REPRESENTATIONS,  WARRANTIES  AND  COVENANTS  OF  THE  COMPANY.
       --------------------------------------------------------------

     (a)     Reservation  of  Common  Stock.  The  Common  Stock  issuable  upon
             ------------------------------
exercise  of  the  Warrantholder's  rights  and  the  Common Stock issuable upon
conversion  of  such  Common Stock have been duly and validly reserved and, when
issued  in  accordance  with  the  provisions of this Warrant Agreement, will be
validly  issued,  fully  paid and non-assessable, and will be free of any taxes,
liens, charges or encumbrances of any nature whatsoever; provided, however, that
the  Common  Stock  issuable  pursuant  to this Warrant Agreement and the Common
Stock  issuable  upon  conversion  of  such  Common  Stock  may  be  subject  to
restrictions  on  transfer  under  state  and/or  Federal  securities laws.  The
Company  has  made  available  to  the  Warrantholder true, correct and complete
copies  of its Charter and Bylaws, as amended.  The issuance of certificates for
shares  of  Common  Stock  upon  exercise of the Warrant Agreement shall be made
without  charge to the Warrantholder for any issuance tax in respect thereof, or
other  cost  incurred  by  the  Company in connection with such exercise and the
related issuance of shares of Common Stock. The Company shall not be required to
pay  any  tax  which  may be payable in respect of any transfer involved and the
issuance  and  delivery  of  any  certificate  in  a name other than that of the
Warrantholder.

     (b)     Exempt Transaction.  Subject to the accuracy of the Warrantholder's
             ------------------
representations  in  Section  10  hereof,  the issuance of the Common Stock upon
exercise  of  this  Warrant  will  constitute  a transaction exempt from (i) the
registration requirements of Section 5 of the 1933 Act, in reliance upon Section
4(2)  thereof,  and (ii) the qualifi-cation requirements of the applicable state
securities  laws,  to  the extent that the requirements of Section 5 of the 1933
Act  and  of  the  applicable state securities laws are the same on  the date of
exercise  as  they  are  on  the  date  hereof.

     (c)     Compliance  with  Rule  144.  At  the  written  request  of  the
             ---------------------------
Warrantholder,  who  proposes to sell Common Stock issuable upon the exercise of
the  Warrant,  in  compliance  with  Rule  144 promulgated by the Securities and
Exchange  Commission, the Company shall furnish to the Warrantholder, within ten
(10)  days  after  receipt  of  such request, a written statement confirming the
Company's compliance with the filing requirements of the Securities and Exchange
Commission  as  set forth in such Rule, as such Rule may be amended from time to
time.

<PAGE>

10.     REPRESENTATIONS  AND  COVENANTS  OF  THE  WARRANTHOLDER.
        -------------------------------------------------------

     This  Warrant  Agreement  has  been entered into by the Company in reliance
upon  the  following  representations  and  covenants  of  the  Warrantholder:

     (a)     Investment  Purpose.  The  right  to  acquire Common Stock and  the
             -------------------
Common  Stock  issuable  upon  exercise  of the Warrantholder's rights contained
herein  will  be  acquired  for  investment  and  not with a view to the sale or
distribution of any part thereof, and the Warrantholder has no present intention
of selling or engaging in any public distribution of the same except pursuant to
a  registration  or  exemption.

     (b)     Private  Issue.  The  Warrantholder understands (i) that the Common
             --------------
Stock  issuable  upon  exercise of this Warrant is not registered under the 1933
Act  or  qualified under applicable state securities laws on the ground that the
issuance  contemplated  by  this  Warrant  Agreement  will  be  exempt  from the
registration  and  qualifications  requirements  thereof,  and  (ii)  that  the
Company's  reliance  on  such exemption is predicated on the representations set
forth  in  this  Section  10.

     (c)     Disposition  of  Warrantholder's  Rights.  In  no  event  will  the
             ----------------------------------------
Warrantholder make a disposition of any of its rights to acquire Common Stock or
the  Common  Stock issuable upon exercise of such rights unless and until (i) it
shall  have  notified  the  Company  of  the  proposed  disposition, and (ii) if
requested by the Company, it shall have furnished the Company with an opinion of
counsel  (which  counsel  may  either  be  inside  or  outside  counsel  to  the
Warrantholder)  satisfactory  to  the Company and its counsel to the effect that
(A)  appropriate  action  necessary  for  compliance  with the 1933 Act has been
taken, or (B) an exemption from the registration requirements of the 1933 Act is
available.  Notwithstanding  the  foregoing,  the  restrictions imposed upon the
transferability of any of its rights to acquire the Common Stock issuable on the
exercise  of  such rights do not apply to transfers from the beneficial owner of
any  of the aforementioned securities to its nominee or from such nominee to its
beneficial owner (including, but not limited to any distribution to the partners
of  the Warrantholder), and shall terminate as to any particular share of Common
Stock  or  Common  Stock  when  (1)  such  security  shall have been effectively
registered  under the 1933 Act and sold by the holder thereof in accordance with
such registration or (2) such security shall have been sold without registration
in  compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been
issued  to  the  Warrantholder at its request by the staff of the Securities and
Exchange  Commission  or a ruling shall have been issued to the Warrantholder at
its  request  by  such Commission stating that no action shall be recommended by
such  staff or taken by such Commission, as the case may be, if such security is
transferred  without  registration  under  the  1933  Act in accordance with the
conditions  set  forth  in  such  letter  or  ruling  and  such letter or ruling
specifies  that  no  subsequent restrictions on transfer are required.  Whenever
the restrictions imposed hereunder shall terminate, as hereinabove provided, the
Warrantholder  or holder of a share of Common Stock then outstanding as to which
such restrictions have terminated shall be entitled to receive from the Company,
without  expense to such holder, one or more new certificates for the Warrant or
for such shares of Common Stock or Common Stock issuable upon conversion of such
Common  Stock  not  bearing  any  restrictive  legend.

<PAGE>

     (d)     Financial  Risk.  The  Warrantholder  has  such  knowledge  and
             ---------------
experi-ence in financial and business matters as to be capable of evaluating the
merits  and  risks  of  its investment, and has the ability to bear the economic
risks  of  its  investment.

     (e)     Risk of No Registration.  The Warrantholder understands that if the
             -----------------------
Company  does  not register with the Securities and Exchange Commission pursuant
to  Section  12  of  the  1934 Act (the "1934 Act"), or file reports pursuant to
Section  15(d),  of  the  1934  Act, or if a registration statement covering the
securities  under  the 1933 Act is not in effect when it desires to sell (i) the
rights  to purchase Common Stock pursuant to this Warrant Agreement, or (ii) the
Common  Stock issuable upon exercise of the right to purchase it may be required
to  hold  such  securities  for  an  indefinite  period.  The Warrantholder also
understands  that any sale of its rights of the Warrantholder to purchase Common
Stock,  or  Common  Stock issuable on the exercise of such rights which might be
made  by  it  in  reliance  upon Rule 144 under the 1933 Act may be made only in
accordance  with  the  terms  and  conditions  of  that  Rule.

     (f)     Accredited  Investor.  Warrantholder  is  an  "accredited investor"
             --------------------
within  the  meaning of the Securities and Exchange Rule 501 of Regulation D, as
presently  in  effect.

11.     TRANSFERS.
        ---------

     Subject  to  the terms and conditions con-tained in Section 10 hereof, this
Warrant  Agreement and all rights hereunder are transferable in whole or in part
by  the  Warrantholder  and  any  successor transferee, provided, however, in no
event  shall  (i)  the number of transfers of the rights and interests in all of
the  Warrants  exceed  three  (3)  transfers and (ii) the transferee be a direct
competitor  of  the Company, unless an "Event of Default" as defined in the Loan
Agreement  has  occurred,  in  which  event  this  Warrant  Agreement  shall  be
transferable  to any transferee.  The transfer shall be recorded on the books of
the  Company  upon  receipt  by  the Company of a notice of transfer in the form
attached hereto as Exhibit III (the "Transfer Notice"), at its principal offices
and  the  payment  to  the  Company of all transfer taxes and other governmental
charges  imposed  on  such  transfer.

12.     MISCELLANEOUS.
        -------------

     (a)     Effective Date.  The provisions of this Warrant Agree-ment shall be
             --------------
construed  and  shall be given effect in all respects as if it had been executed
and  delivered  by the Company on the date hereof.  This Warrant Agreement shall
be  binding  upon  any  successors  or  assigns  of  the  Company.

     (b)     Attorney's  Fees.  In  any  litigation,  arbitration  or  court
             ----------------
proceeding  between  the  Company  and  the  Warrantholder  relating hereto, the
prevailing party shall be entitled to attorneys' fees and expenses and all costs
of  proceedings  incurred  in  enforcing  this  Warrant  Agreement.

<PAGE>

     (c)     Governing  Law.  This  Warrant  Agreement  shall be governed by and
             --------------
construed for all purposes under and in accordance with the laws of the State of
New  Jersey.

     (d)     Counterparts.  This  Warrant  Agreement  may  be executed in two or
             ------------
more  counterparts,  each of which shall be deemed an original, but all of which
together  shall  constitute  one  and  the  same  instrument.

     (e)     Notices.  Any notice required or permitted hereunder shall be given
             -------
in  the  manner  set  forth  in  the  Loan  Agreement.

     (f)     Remedies.  In  the  event  of  any  default  hereunder,  the
             --------
non-defaulting  party  may  proceed  to protect and enforce its rights either by
suit  in  equity and/or by action at law, including but not limited to an action
for  damages  as  a  result  of  any such default, and/or an action for specific
performance for any default where Warrantholder will not have an adequate remedy
at  law  and  where  damages  will  not  be  readily  ascertainable. The Company
expressly agrees that it shall not oppose an application by the Warrantholder or
any  other  person  entitled to the benefit of this Agreement requiring specific
performance  of  any  or  all  provisions  hereof  or enjoining the Company from
continuing  to  commit  any  such  breach  of  this  Agreement.

     (g)     No Impairment of Rights.  The Company will not, by amendment of its
             -----------------------
Charter  or  through  any  other means, avoid or seek to avoid the observance or
performance  of  any of the terms of this Warrant, but will at all times in good
faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate in order to protect the rights of the
Warrantholder  against  impairment.

     (h)     Survival.  The  representations,  warranties,  covenants  and
             --------
conditions  of  the respective parties contained herein or made pursuant to this
Warrant  Agreement  shall  survive  the  execution  and delivery of this Warrant
Agreement.

     (i)     Severability.  In  the  event  any one or more of the provisions of
             ------------
this  Warrant  Agreement  shall  for  any  reason  be  held  invalid, illegal or
unenforceable,  the  remaining  provisions  of  this  Warrant Agreement shall be
unimpaired,  and  the  invalid,  illegal  or  unenforceable  provision  shall be
replaced  by a mutually acceptable valid, legal and enforceable provision, which
comes closest to the intention of the parties underlying the invalid, illegal or
unenforceable  provision.

     (j)     Amendments.  Any provision of this Warrant Agreement may be amended
             ----------
by  a  written  instrument  signed  by  the  Company  and  by the Warrantholder.

                  (REMAINDER OF PAGE LEFT INTENTIONALLY BLANK)

<PAGE>

     IN  WITNESS  WHEREOF, the parties hereto have caused this Warrant Agreement
to  be  executed  by  its officers thereunto duly authorized as of the Effective
Date.

                    COMPANY:  WORLDWIDE  MEDICAL  CORPORTAION

                    By:     /s/ Daniel G. McGuire
                            ______________________
                            Daniel G. McGuire

                    Title:  President

                    WARRANTHOLDER:  ZIEGLER  HEALTHCARE  FUND  I,  LP

                    By:     /s/ Douglas Korey
                            ____________________
                            Douglas A. Korey

                    Title:  Member

<PAGE>

                                    EXHIBIT I

                               NOTICE OF EXERCISE

TO:     ____________________________

(1)     The  undersigned  Warrantholder hereby elects to purchase _______ shares
of  the  Common Stock of _________________, pursuant to the terms of the Warrant
Agreement  dated  the  18th  day  of  September,  2002 (the "Warrant Agreement")
between  Worldwide  Medical  Corporation  and  the  Warrantholder,  and  tenders
herewith  payment  of  the purchase price for such shares in full, together with
all  applicable  transfer  taxes,  if  any.

(2)     In  exercising  its  rights  to  purchase  the  Common  Stock  of
________________________________________,  the  undersigned  hereby confirms and
acknowledges the investment representations and warranties made in Section 10 of
the  Warrant  Agreement.

(3)     Please  issue a certificate or certificates repre-senting said shares of
Common  Stock  in  the  name  of  the  under-signed  or in such other name as is
specified  below.

_________________________________
(Name)

_________________________________
(Address)

WARRANTHOLDER:  ZIEGLER  HEALTHCARE  FUND  I,  LP

By:     _________________________

Title:     _________________________

Date:     _________________________

<PAGE>
                                   EXHIBIT II

                           ACKNOWLEDGMENT OF EXERCISE

     The  undersigned ____________________________________, hereby acknowl-edges
receipt  of  the  "Notice  of  Exercise"  from  Ziegler Healthcare Fund I, LP to
purchase  ____  shares  of  the  Common  Stock of Worldwide Medical Corporation,
pursuant  to  the  terms of the Warrant Agreement, and further acknowledges that
______  shares  remain  subject  to  purchase  under  the  terms  of the Warrant
Agreement.

                         COMPANY:  WORLDWIDE  MEDICAL  CORPORATION

                         By:     _________________________

                         Title:     _________________________

                         Date:     _________________________

<PAGE>
                                   EXHIBIT III

                                 TRANSFER NOTICE

(TO  TRANSFER  OR  ASSIGN  THE FOREGOING WARRANT AGREEMENT EXECUTE THIS FORM AND
SUPPLY  REQUIRED  INFORMATION.  DO  NOT  USE  THIS  FORM  TO  PURCHASE  SHARES.)

     FOR  VALUE  RECEIVED,  the  foregoing  Warrant  Agreement  and  all  rights
evidenced  thereby  are  hereby  transferred  and  assigned  to

_________________________________________________________________
(Please  Print)

whose  address  is___________________________________________________

_________________________________________________________________

               Dated:     ____________________________________

               Holder's  Signature:     _____________________

               Holder's  Address:          _____________________

               ___________________________________________

Signature  Guaranteed:     ____________________________________________

NOTE:     The signature to this Transfer Notice must correspond with the name as
it  appears  on  the  face  of  the  Warrant  Agreement,  without  alteration or
enlargement or any change whatever. Officers of corporations and those acting in
a  fiduciary  or  other  representative  capacity should file proper evidence of
authority  to  assign  the  foregoing  Warrant  Agreement.

<PAGE>RIGHTS AGREEMENT

     This  Rights  Agreement  (this  "AGREEMENT") is made and entered into as of
September  18,  2002 among Worldwide Medical Corporation, a Delaware corporation
(the  "COMPANY"),  Ziegler Healthcare Fund I, LP, a Delaware limited partnership
("ZIEGLER"),  those persons or entities listed on Exhibit A hereof (collectively
                                                  ---------
referred  to  as  the  "HOLDERS").

     WHEREAS,  the  Company  has  entered  into  those  certain  Loan Agreement,
Promissory  Note,  Security  Agreement,  and  Warrant  and certain other related
documents  and instruments referred to or in connection with such Loan Agreement
(collectively,  the  "TRANSACTION  AGREEMENTS")  with  Ziegler,  of  even  date
herewith,  under  which  the  Company borrowed certain funds from Ziegler and in
exchange  therefore,  issued  to Ziegler a warrant for the purchase of 2,475,000
shares  of  the  Common  Stock  of  the  Company, and also has agreed to provide
Ziegler  with  certain  other  rights  set  forth  herein. The execution of this
Agreement  is  a  simultaneous  condition  to the obligations of the Company and
Ziegler  under  the  Transaction  Agreements.

     WHEREAS,  capitalized  terms  used herein but not defined herein shall have
the  meanings  as  set  forth  in  the  Transaction  Agreements.

     NOW  THEREFORE,  it  is  hereby  agreed  as  follows:

                                    ARTICLE 1
                               REGISTRATION RIGHTS

1.1     CERTAIN  DEFINITIONS.

     As  used  in  this  Agreement, the following terms shall have the following
respective  meanings:

     (a)     "AFFILIATE"  has  the  meaning  ascribed  thereto  in  Rule  405
promulgated  under  the  Securities  Act.

     (b)     "BUSINESS  DAY"  means  any  day,  other than a Saturday, Sunday or
legal  holiday,  on  which banks in the State of New York are open for business.

     (c)     "COMMISSION"  means  the  Securities  and  Exchange  Commission.

     (d)     "COMMON  STOCK"  means the Common Stock, par value $0.01 per share,
of  the  Company,  as constituted on the date hereof, any shares into which such
Common  Stock  shall  have  been  changed,  or  any  shares  resulting  from any
reclassification  of  such  Common  Stock.

     (e)     "COMMON  STOCK  EQUIVALENTS"  means  (without  duplication with any
Common  Stock  or  other  Common  Stock  Equivalents) rights, warrants, options,
convertible  securities,  or  exchangeable  securities or indebtedness, or other
rights,  exercisable  for  or  convertible  or  exchangeable  into,  directly or
indirectly,  Common  Stock  or  securities  exercisable  for  or  convertible or
exchangeable  into  Common  Stock,  whether  at the time of issuance or upon the
passage  of  time  or  the  occurrence  of  some  future  event.

<PAGE>

     (f)     "EXCHANGE  ACT"  means  the  Securities  Exchange  Act  of 1934, as
amended,  or any successor statute thereto, and the rules and regulations of the
Commission  promulgated  thereunder,  all  as the same shall be in effect at the
time.

     (g)     "FULLY-DILUTED  SHARES" means, as of any date of determination, the
shares  of  Common  Stock  outstanding  and  (without duplication) all shares of
Common  Stock  issuable, whether at such time or upon the passage of time or the
occurrence  of  future  events, upon the exercise, conversion or exchange of all
then  outstanding  Common  Stock  Equivalents.

     (h)     "HOLDERS"  means  the  Holders  referred to in the Preamble and any
other  Person  holding  Registrable Securities to whom these registration rights
have  been  assigned  pursuant  to  Section  2.1  of  this  Agreement.

     (i)     "PERSON"  shall  mean  an  individual,  partnership,  corporation,
limited  liability  company,  association,  trust,  estate,  joint  venture,
unincorporated  organization  and  any  government,  governmental  department or
agency  or  political  subdivision  thereof.

     (j)     "REGISTRABLE SECURITIES" means (i) any Common Stock issued and held
at  any  time by any Holder or Ziegler; (ii) any Common Stock held by any Holder
or Ziegler issued or issuable pursuant to the exercise by such Holder or Ziegler
of his, her, or its option, warrant, or other right to acquire Common Stock; and
(iii)  securities  issued  in  replacement or exchange, or upon any stock split,
stock  dividend,  recapitalization  or  similar  event, of any of the securities
issued  in  clauses  (i)  or  (ii)  above.

     (k)     "REGISTRATION  EXPENSES"  means  all  expenses  incident  to  the
Company's  performance  of or compliance with this Agreement, including, without
limitation,  all  registration,  filing,  listing  and  National  Association of
Securities  Dealers, Inc. ("NASD") fees, all fees and expenses of complying with
securities  or  blue  sky  laws,  all  word processing, duplicating and printing
expenses,  all messenger and delivery expenses, any transfer taxes, the fees and
expenses  of  the  Company's  legal  counsel and independent public accountants,
including  the expenses of any special audits or "cold comfort" letters required
by or incident to such performance and compliance, fees and disbursements of one
counsel  for  all of the Holders, and any fees and disbursements of underwriters
customarily  paid  by insurers or sellers of securities; provided, however, that
                                                         --------  -------
Registration  Expenses shall not include underwriting discounts and commissions.

     (l)     "REGISTRATION  STATEMENT"  means  a registration statement filed by
the Company  with the Commission for a public offering and sale of securities of
the  Company.

     (m)     "SECURITIES  ACT"  means the Securities Act of 1933, as amended, or
any  successor  statute thereto, and the rules and regulations of the Commission
promulgated  thereunder,  all  as  the  same  shall  be  in  effect at the time.

<PAGE>

1.2     DEMAND  REGISTRATION

     (a)     Demand  Registration.  If  the Company shall receive, at any time a
             ---------------------
written  request  from  Ziegler  that  the Company file a registration statement
under  the  Act  covering  the  registration of Registrable Securities, then the
Company  shall, within ten (10) days of the receipt thereof, give written notice
of  such request to Ziegler and shall, as soon as practicable and subject to the
terms  of  this  Section  1.2,  use its best efforts to effect such registration
(including,  without  limitation, appropriate registration under applicable blue
sky  or  other  state securities laws and appropriate compliance with applicable
regulations  issued  under  the  Securities  Act  and  any  other  governmental
requirements  or  regulations)  as  may be so requested and as may be reasonably
required  to  permit  or  facilitate  the  sale  and  distribution of all of the
Registrable  Securities  as  are  owned  by  Ziegler  as  of  the  date thereof.

     (b)     Limitations.
             ------------

     (i)     The  Company  shall  be  entitled to postpone for up to ninety (90)
days the commencement of any registration process (prior to effectiveness of the
related  registration  statement)  pursuant  to this Section 1.2 if the Board of
Directors  of  the Company determines, in its good faith reasonable judgment, it
would  be  seriously  detrimental  to  the Company and its stockholders for such
registration  statement  to  be  effected  at such time and the Company promptly
gives notice to Ziegler of such determination, provided however, the Company may
not  utilize  this  right  more  than  once  in  any  twelve  (12) month period.

     (ii)     The  Company  shall  not  be  obligated  to effect, or to take any
action  to  effect,  any  registration  pursuant  to this Section 1.2 during the
period  starting with the date sixty (60) days prior to the Company's good faith
estimate  of  the  date  of  filing  of, and ending on a date 180 days after the
effective  date  of, a registration subject to Section 1.3 hereof, provided that
the  Company is actively employing in good faith all reasonable efforts to cause
such  registration  statement  to  become  effective.

     (c)     Limitation  on  Number  of  Demand  Registrations.
             -------------------------------------------------

     (i)     The  Company  shall  not  be  obligated  to  effect  more  than one
registration  pursuant  to  Section  1.2  (a "DEMAND SUBSECTION") on Form S-1 or
other  applicable  form  as  promulgated  by  the  Commission.

     (ii)     A  Demand  Registration  shall not be deemed to have been effected
unless  (x)  the  registration  statement  in  respect thereof has been declared
effective  by  the Commission and (y) such registration has not been terminated,
withdrawn  or  stopped  and  has  not  required  amendment or supplementation as
contemplated  by Section 1.5(a)(vi) or (ix), as the case may be; provided that a
Demand  Registration shall not be deemed to be effected by the Company if, prior
to the date on which the related registration statement is declared effective by
the  Commission,  Ziegler  withdraws  all  securities  to  be sold by it and its
Affiliates  therefrom,  in  which  event  the  Company  shall not be required to
continue  the registration process unless (A) Ziegler, pursuant to another right
contained  herein  so  requests that such registration be deemed initiated by it
under  such  Subsection  or (B) the Company otherwise determines, in which event
such  registration  shall  be  deemed  to  be  a  piggy-back  registration.

<PAGE>

     (d)     Expenses.  The Company shall bear and pay all Registration Expenses
             --------
incurred  in  connection  with any Demand Registration effected pursuant to this
Section  1.2.

     (e)     Priority  in Demand Registration.  If Ziegler intends to distribute
             --------------------------------
the  Registrable  Securities covered by its request by means of an underwriting,
it  shall  so  advise the Company as a part of its request made pursuant to this
Section  1.2,  and  the  Company  shall  include such information in the written
notice  referred  to  in  Section 1.2(a).  In such event, the right of any other
Holder  to  include  Registrable  Securities  in  such  registration  shall  be
conditioned  upon  such  Holder's  participation  in  such underwriting.  If the
managing  underwriters  shall  give written advice to the Company that, in their
opinion,  market conditions dictate that no more than a specified maximum number
of  Registrable  Securities  could  successfully  (as  to price and quantity) be
included  in  such registration, then the Company shall so advise all Holders of
Registrable  Securities  which  would otherwise be underwritten pursuant hereto,
and  the  number of shares of Registrable Securities that may be included in the
underwriting  shall be allocated among all Holders thereof, first to Ziegler and
then to all other Holders in proportion (as nearly as practicable) to the amount
of  Registrable  Securities  owned  by  each Holder; provided, however, that the
number  of  Registrable Securities to be included in such underwriting shall not
be  so  reduced unless all other securities are first entirely excluded from the
underwriting.

1.3     INCIDENTAL  REGISTRATION.

     (a)     Incidental  Registration.     If  the  Company for itself or any of
             ------------------------
its  security holders shall at any time or times after the date hereof determine
to  register  under  the Securities Act any shares of its capital stock or other
securities  (other  than:  (i)  the  registration  of  an  offer,  sale or other
disposition  of  securities  solely  to employees of, or other persons providing
services  to,  the Company, or any subsidiary pursuant to an employee or similar
benefit  plan; or (ii) relating to a merger, acquisition or other transaction of
the  type  described  in  Rule  145  under the Securities Act or a comparable or
successor  rule,  registered on Form S-4 or similar or successor forms), on each
such occasion the Company will notify each Holder of such determination at least
thirty  (30)  days  prior to the filing of such Registration Statement, and upon
the  request  of  Ziegler  given  in  writing  within twenty (20) days after the
receipt  of  such  notice,  the  Company  will  use  its best efforts as soon as
practicable  thereafter  to cause any of the Registrable Securities specified by
Ziegler  to  be  included  in  such  Registration  Statement  to the extent such
registration  is  permissible  under  the  Securities  Act  and  subject  to the
conditions  of  the  Securities  Act  (an  "INCIDENTAL  REGISTRATION").

     (b)     Expenses.     The  Company  shall  pay  all  Registration  Expenses
             --------
incurred  in  connection  with  any Incidental Registration effected pursuant to
this  Section  1.3.

<PAGE>

     (c)     Priority  in  Incidental  Registration.
             --------------------------------------

     (i)     If  an Incidental Registration is an underwritten registration, and
the  managing  underwriters  shall  give  written advice to the Company that, in
their  opinion,  market conditions dictate that no more than a specified maximum
number of securities (the "UNDERWRITER'S MAXIMUM NUMBER") could successfully (as
to price and quantity) be included in such Incidental Registration, then subject
to  Section  1.3(c)(ii)  below:  (A) the Company shall be entitled to include in
such  registration that number of securities which the Company proposes to offer
and  sell for its own account in such registration and which does not exceed the
Underwriter's Maximum Number; and (B) the Company will be obligated and required
to  include in such registration that number of shares of Registrable Securities
which  shall have been requested by Ziegler which does not exceed the difference
between the Underwriter's Maximum Number and that number of securities which the
Company  is  entitled  to  include therein pursuant to clause (A) above. If less
than  all  of  the  Registrable  Securities requested to be included in any such
registration  by  Ziegler can be so included due to these priority requirements,
then  Ziegler's  request  shall be granted on an pro rata basis with the Company
and  any  other  Holders  having  similar  rights.

     (ii)     In  all underwritten Incidental Registrations, the Company will be
obligated  and required to include at least 25% of the shares of the Registrable
Securities  of  Ziegler,  if  requested,  under  this  Section 1.3 (the "MINIMUM
PIGGYBACK  AMOUNT").  To  the  extent  the  Minimum Piggyback Amount exceeds the
difference  between  the  Underwriter's  Maximum  Number  and  that  number  of
securities  which  the  Company  proposes to offer and sell for its own account,
then  the Company shall reduce the number of securities it proposes to offer and
sell  for  its  own  account  by  such  excess  amount.

     (d)     Withdrawal.  Notwithstanding  any  other  term or provision of this
             ----------
Agreement  to  the  contrary,  the  Company shall at all times have the right to
withdraw,  cancel  or terminate any registration, to which the rights under this
Section  1.3  apply,  at  any  time  and  for  any  reason in the Company's sole
discretion.

1.4     FORM  S-3  REGISTRATION.

     (a)     S-3  Registration.  If  the Company shall receive a written request
             -----------------
from  Ziegler  that  the  Company effect a registration on Form S-3 covering the
registration  of  Registrable  Securities,  then  the  Company  shall:

     (i)     promptly  give written notice of the proposed registration, and any
related  qualification  or  compliance, to all other Holders having registration
rights;

     (ii)     as  soon  as  practicable,  effect  such registration and all such
qualifications  and  compliance  as  may  be so requested and as would permit or
facilitate  the sale and distribution of all or of the Registrable Securities as
are  owned  by Ziegler as of the date thereof, together with all or such portion
of the Registrable Securities of any other Holders having rights to join in such
request  as  are  specified  in  a written request given within thirty (30) days
after  receipt  of such written notice from the Company; provided, however, that
the  Company  shall  not  be  obligated  to  effect  any  such  registration,
qualification  or  compliance,  pursuant  to  this  Section  1.4

<PAGE>

     (A)     if  Form  S-3  is  not  available  for  such  offering  by Ziegler;

     (B)     if the Company shall furnish to Ziegler a certificate signed by the
President of the Company stating that in the good faith judgment of the Board of
Directors  of  the Company, it would be seriously detrimental to the Company and
its  stockholders for such Form S-3 registration to be effected at such time, in
which event the Company shall have the right to defer the filing of the Form S-3
registration  statement  for  a  period  of not more than ninety (90) days after
receipt  of  the  request  of Ziegler under this Section 1.4, provided, however,
that  the Company shall not utilize this right more than once in any twelve (12)
month  period;

     (C)     if  the  Company has effected two (2) S-3 registrations pursuant to
this Section 1.4 and such registrations have been declared or ordered effective;
or

     (D)     in  any  particular  jurisdiction  in  which  the  Company would be
required to qualify to do business or to execute a general consent to service of
process  in  effecting  such  registration,  qualification  or  compliance.

     (b)     Expenses,  etc.  The  Company  shall  bear and pay all Registration
             ---------------
Expenses incurred in connection with any registration effective pursuant to this
Section  1.4.  Registrations  effected pursuant to this Section 1.4 shall not be
counted as demands for registration or registrations pursuant to Sections 1.2 or
1.3.

     (c)     Priority  in  Registration.  If  Ziegler,  pursuant to Section 1.4,
             --------------------------
intends to distribute the Registrable Securities covered by its request by means
of an underwriting, it shall so advise the Company as a part of its request made
pursuant  to this Section 1.4, and the Company shall include such information in
the  written notice referred to in Section 1.4(a).  In such event, the right, if
any,  of any other Holder to include Registrable Securities in such registration
shall  be conditioned upon such Holder's participation in such underwriting.  If
the  managing  underwriters  shall  give  written advice to the Company that, in
their  opinion,  market conditions dictate that no more than a specified maximum
number  of  Registrable  Securities  could  successfully  be  included  in  such
registration,  then  the  Company  shall  so  advise  all Holders of Registrable
Securities which would otherwise be underwritten pursuant hereto, and the number
of  shares  of  Registrable  Securities that may be included in the underwriting
shall  be  allocated  first  to Ziegler, and then among all other Holders having
rights  to  participate therein, in proportion (as nearly as practicable) to the
amount  of  Registrable Securities owned by each such Holder; provided, however,
that  the  number  of Registrable Securities to be included in such underwriting
shall  not be so reduced unless all other securities are first entirely excluded
from  the  underwriting.

1.5     REGISTRATION  PROCEDURES.

     (a)     If  and  whenever the Company undertakes to effect the registration
of  any  Registrable Securities under the Securities Act as provided in Sections
1.2,  1.3  or 1.4, the Company, as expeditiously as practical and subject to the
terms  and conditions of Sections 1.2, 1.3 or 1.4, including the Company's right
under  Section  1.3(d),  will:

<PAGE>

     (i)     prepare  and  file  with  the Commission the requisite Registration
Statement  to  effect such registration and use reasonable efforts to cause such
registration  to become and remain effective for up to 180 days (or such shorter
period  of  time  as  the  underwriters need to complete the distribution of the
registered offering, or one year in the case of a "shelf" Registration Statement
on  Form  S-3), and from time to time will amend or supplement such Registration
Statement and the prospectus contained therein to the extent necessary to comply
with  the  Securities  Act  and  any  applicable  state  securities  statute  or
regulation;

     (ii)     permit  any  Holder  (including  Ziegler) which, in the reasonable
judgment  of  the Holder (or Ziegler), might be deemed to be an underwriter or a
controlling  person  of  the  Company, to participate in the preparation of such
Registration  Statement  and  to  require  the  insertion  therein  of material,
furnished  to  the  Company in writing, which in the reasonable judgment of such
Holder  and  its  counsel  should  be  included;

     (iii)     furnish  to  Ziegler  and  the  other  participating Holders such
number  of  conformed  copies  of  such  Registration Statement and of each such
amendment  and  supplement  thereto  (in each case including all exhibits), such
number  of  copies  of  the  prospectus contained in such Registration Statement
(including each preliminary prospectus and any summary prospectus) and any other
prospectus filed under Rule 424 under the Securities Act, in conformity with the
requirements  of the Securities Act, and such other documents, as Ziegler or any
other  Holder  of  Registrable  Securities  to  be  sold under such Registration
Statement  may  reasonably  request;

     (iv)     use  reasonable  efforts  to  register  or qualify all Registrable
Securities covered by such Registration Statement under such other United States
and  state  securities  or blue sky laws of such jurisdictions as Ziegler or any
Holder  of  Registrable  Securities to be sold under such Registration Statement
shall  reasonably  request, to keep such registration or qualification in effect
for  so  long  as such registration remains in effect, and take any other action
which  may  be reasonably necessary or advisable to enable Ziegler or the Holder
of  Registrable  Securities  to  be  sold  under  such Registration Statement to
consummate  the  disposition  in  such  jurisdictions of the securities owned by
Ziegler  or  such Holder, except that the Company shall not for any such purpose
be  required to (a) qualify generally to do business as a foreign corporation in
any  jurisdiction  wherein  it  would  not  but  for  the  requirements  of this
subdivision  (iv)  be  obligated  to  be  so qualified, or (b) subject itself to
taxation  in  any  such  jurisdiction;

     (v)     use  reasonable efforts to cause all Registrable Securities covered
by  such  Registration Statement to be registered with or approved by such other
United States and state governmental agencies or authorities as may be necessary
to  enable Ziegler or the Holder of Registrable Securities to be sold under such
Registration  Statement  to  consummate  the  intended  disposition  of  such
Registrable  Securities;

<PAGE>

     (vi)     in  the  event  of  the  issuance of any stop order suspending the
effectiveness  of  the  Registration  Statement,  or  of any order suspending or
preventing  the use of any related prospectus or suspending the qualification of
any  Registrable  Securities included in such Registration Statement for sale in
any  jurisdiction, the Company shall use its best efforts promptly to obtain the
withdrawal  of  such  order;

     (vii)     use  reasonable  efforts to furnish to Ziegler and the Holders of
Registrable  Securities  to  be sold under such Registration Statement a letter,
dated  the  effective  date  of the Registration Statement, from the independent
certified  public  accountants of the Company, addressed to the underwriters, if
any,  and  to the Holders making such request, stating that they are independent
certified  public  accountants within the meaning of the Securities Act and that
in the opinion of such accountants, the financial statements and other financial
data of the Company included in the Registration Statement or the prospectus, or
any  amendment or supplement thereto, comply as to form in all material respects
with  the  applicable  accounting  requirements  of  the  Securities  Act;

     (viii)     use  reasonable efforts to furnish to Ziegler and the Holders of
Registrable  Securities to be sold under such Registration Statement the opinion
of  counsel  to the Company, addressed to the underwriters, if any, and covering
such  matters  as  are  customarily  the  subject  of  such  opinion;

     (ix)     immediately  notify  Ziegler  and  the  Holders  of  Registrable
Securities included in such Registration Statement at any time when a prospectus
relating  thereto  is  required to be delivered under the Securities Act, of the
happening  of  any  event  as  result  of  which the prospectus included in such
Registration  Statement,  as  then  in  effect,  includes an untrue statement of
material  fact or omits to state any material fact required to be stated therein
or  necessary  to make the statements therein not misleading in the light of the
circumstances  under  which they were made, and at the request of Ziegler or the
Holders  of  Registrable  Securities promptly prepare and furnish to Ziegler and
such Holders a reasonable number of copies of a supplement to or an amendment of
such  prospectus  as  may  be  necessary so that, as thereafter delivered to the
purchasers  of  such  securities,  such  prospectus  shall not include an untrue
statement  of  a  material  fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading in the
light  of  the  circumstances  under  which  they  were  made;

     (x)     provide  a transfer agent for all Registrable Securities covered by
such  Registration  Statement  and  a  CUSIP  number  for  all  such Registrable
Securities  not  later  than  the effective date of such Registration Statement;

     (xi)     use  reasonable efforts to list all Registrable Securities covered
by  such  Registration  Statement on any securities exchange on which any of the
Registrable  Securities  are  then  listed;  and

     (xii)     issue  (or  cause  the transfer agent of the Company to issue) to
the  purchasers  of such Registrable Securities, a certificate representing such
shares  purchased.

<PAGE>

     (b)     The  Company  may  require  Ziegler  and each Holder of Registrable
Securities  to  be  sold  under  such  Registration  Statement, at the Company's
expense, to furnish the Company with such information and undertakings as it may
reasonably  request  regarding  Ziegler and such Holders and the distribution of
such  securities  as  the  Company  may  from time to time reasonably request in
writing.

     (c)     Ziegler  and Each Holder of Registrable Securities, by execution of
this Agreement, agrees (A) that upon receipt of any notice of the Company of the
happening  of any event of the kind described in Section 1.5(a)(ix), Ziegler and
such Holder will forthwith discontinue its disposition of Registrable Securities
pursuant  to  the Registration Statement relating to such Registrable Securities
until  the  receipt by Ziegler and such Holder of the copies of the supplemented
or  amended prospectus contemplated by Section 1.5(a)(ix) and, if so directed by
the  Company,  will  deliver to the Company all copies other than permanent file
copies, then in possession of Ziegler and the Holders of the prospectus relating
to such Registrable Securities current at the time of receipt of such notice and
(B)  that  it will immediately notify the Company, at any time when a prospectus
relating  to  the  registration of such Registrable Securities is required to be
delivered under the Securities Act, of the happening of any event as a result of
which  information previously furnished by Ziegler or such Holder to the Company
for inclusion in such prospectus contains an untrue statement of a material fact
or  omits  to state any material fact required to be stated therein or necessary
to  make the statements therein not misleading in the light of the circumstances
under  which  they  were  made.  In  the  event the Company, Ziegler or any such
Holder  shall  give any such notice, the period referred to in Section 1.5(a)(i)
shall  be  extended  by  a number of days equal to the number of days during the
period  from  and including the giving of notice pursuant to subdivision Section
1.5(a)(ix)  to  and  including the date when such Holder shall have received the
copies  of  the  supplemented  or  amended  prospectus  contemplated  by Section
1.5(a)(ix).

1.6     UNDERWRITTEN  OFFERINGS.

     In  connection  with  any  underwritten offering pursuant to a registration
requested  under  Sections  1.2,  1.3  or  1.4,  the  Company will enter into an
underwriting  agreement with the underwriters, reasonably acceptable to Ziegler,
for such offering, such agreement (subject to the following sentence) to contain
such  representations  and warranties by the Company and such other terms as are
customarily contained in agreements of that type.  Ziegler and any participating
Holder  of  Registrable  Securities  must  execute  such underwriting agreement;
provided  that  Ziegler  and  no  Holder of Registrable Securities executing any
underwriting  agreement  shall  be  required  to  make  any  representations  or
warranties  to  the  Company or the underwriters (other than representations and
warranties  regarding Ziegler, or such Holder, or the Registrable Securities and
the  intended  method  of  distribution,  and  any  other  representations  and
warranties agreed upon by Ziegler included in such offering) or to undertake any
indemnification  obligations  to  the  Company  or the underwriters with respect
thereto,  except as otherwise provided in Section 1.8 hereof or as otherwise may
be  agreed  upon  by  Ziegler;  provided, however, that the Company shall not be
liable  for  any  breach  of this Agreement if Ziegler declines to enter into an
underwriting  agreement  which  varies  the  terms  hereof.

<PAGE>

1.7     PREPARATION,  REASONABLE  INVESTIGATION.

     In  connection  with  the  preparation  and  filing  of  each  Registration
Statement under the Securities Act, the Company will give Ziegler and any of the
Holders  of Registrable Securities to be sold under such Registration Statement,
the  underwriters,  if any, and their respective counsel and accountants, drafts
and  final  copies  of  such  Registration  Statement,  each prospectus included
therein  or  filed  with the Commission and each amendment thereof or supplement
thereto,  at  least  five (5) business days prior to the filing thereof with the
Commission,  and will give each of them such access to its books and records and
such  opportunities to discuss the business of the Company with its officers and
the  independent  public accountants who have certified its financial statements
as  shall be necessary prior to the filing of the Registration Statement, in the
reasonable opinion of such Holders and such underwriters' respective counsel, to
conduct  a  reasonable  investigation  within the meaning of the Securities Act.

1.8     INDEMNIFICATION  AND  CONTRIBUTION.

     (a)     Indemnification  by  the Company.  In the event of any registration
             --------------------------------
under the Securities Act pursuant to Sections 1.2, 1.3 or 1.4 of any Registrable
Securities  covered  by  such  registration,  the Company will, and hereby does,
indemnify and hold harmless Ziegler and each Holder of Registrable Securities to
be sold under such Registration Statement, each other Person who participates as
an  underwriter  in  the  offering or sale of such securities (if so required by
such  underwriter  as  a  condition  to  including the Registrable Securities of
Ziegler and the Holders in such registration) and each other person, if any, who
controls  Ziegler  or any such Holder or any such underwriter within the meaning
of  the  Securities  Act  (collectively, the "INDEMNIFIED PARTIES"), against any
losses,  claims,  damages  or liabilities, joint or several, to which Ziegler or
the  Holders  or  underwriter or controlling person may become subject under the
Securities  Act  or  otherwise,  insofar  as  such  losses,  claims,  damages or
liabilities, jointly or severally, (or actions or proceedings, whether commenced
or  threatened,  in  respect  thereof)  which arise out of or are based upon any
untrue  statement  or alleged untrue statement of any material fact contained in
any Registration Statement under which such securities were registered under the
Securities  Act,  any  preliminary  prospectus,  final  prospectus  or  summary
prospectus  contained therein or any document incorporated therein by reference,
or  any  amendment or supplement thereto, or any omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make
the  statements  therein  not misleading, or which arise out of any violation by
the  Company  of  any rule or regulation promulgated under the Securities Act or
state  securities  law  applicable  to  the  Company  and  relating to action or
inaction  required  of the Company in connection with any such registration, and
the  Company  will  reimburse the Indemnified Parties for any legal or any other
expenses  reasonably  incurred  by  them  in  connection  with  investigating or
defending  any  such  loss,  claim,  liability,  action or proceeding; provided,
however,  that  the  Company shall not be liable to any Indemnified Party in any
such  case to the extent that any such loss, claim, damage, liability (or action
or  proceeding in respect thereof) or expense arises out of or is based upon any
untrue  statement  or  alleged  untrue statement or omission or alleged omission
made  in  such  Registration  Statement,  any such preliminary prospectus, final
prospectus,  summary prospectus, amendment or supplement in reliance upon and in
conformity  with  written  information furnished expressly for use in connection
with  such  registration  to  the  Company  by  such  Indemnified  Party.

<PAGE>

     (b)     Indemnification  by  Ziegler  and  the  Holders.  The  Company  may
             -----------------------------------------------
require, as a condition to including any Registrable Securities of any person or
entity  in  any  Registration  Statement filed pursuant to Section 1.2, that the
Company  shall  have  received an undertaking reasonably satisfactory to it from
such  person or entity to indemnify and hold harmless (in the same manner and to
the  same  extent  as  set  forth  in  subdivision  (a) of this Section 1.8) the
Company,  Ziegler,  and  the  other  Holders, each director of the Company, each
officer  of  the Company and each other Person, if any, who controls the Company
within  the  meaning  of  the  Securities  Act, with respect to any statement or
alleged  statement  in  or  omission  or alleged omission from such Registration
Statement,  any  preliminary  prospectus, final prospectus or summary prospectus
contained therein, or any amendment or supplement thereto, if, and only if, such
statement  or  alleged  statement  or  omission  or alleged omission was made in
reliance  upon  and  in  conformity with information furnished in writing to the
Company  directly  by  such  person  or  entity  specifically  for  use therein;
provided,  however,  that  the  obligation  of  Ziegler or any Holder under this
Section  1.8 shall be limited to an amount equal to the net proceeds received by
Ziegler  or  such  Holder  upon  the  sale of Registrable Securities sold in the
offering  covered  by  such  registration.

     (c)       Notices of Claims, etc.  Promptly after receipt by an Indemnified
               ----------------------
Party  of  notice  of  the  commencement of any action or proceeding involving a
claim  referred  to  in  the  preceding  subdivisions  of this Section 1.8, such
Indemnified  Party  will,  if a claim in respect thereof is to be made against a
party  required  to  provide  indemnification  (an  "INDEMNIFYING  PARTY"), give
written  notice  to  the  latter  of  the commencement of such action, provided,
however,  that  the  failure of any Indemnified Party to give notice as provided
herein  shall  not  relieve  the  Indemnifying Party of its obligation under the
preceding  subdivisions  of  this  Section  1.8,  except  to the extent that the
Indemnifying  Party  is  actually prejudiced by such failure to give notice.  In
case  any  such  action  is brought against an Indemnified Party, unless in such
Indemnified  Party's  reasonable  judgment  a  conflict of interest between such
Indemnified  and  indemnifying  parties  may exist (a "CONFLICT OF INTEREST") in
respect of such claim (in which case that Indemnified Party shall have the right
to retain one separate counsel, with the reasonable fees and expenses to be paid
by  the  Indemnifying  Party),  the  Indemnifying  Party  shall  be  entitled to
participate  in  and  to  assume  the  defense  thereof,  jointly with any other
Indemnifying  Party  similarly  notified  to  the  extent that it may wish, with
counsel reasonably satisfactory to such Indemnified Party, and after notice from
the  Indemnifying  Party  to such Indemnified Party of its election so to assume
the  defense  thereof,  the  Indemnifying  Party  shall  not  be  liable to such
Indemnified  Party  for any legal or other expenses subsequently incurred by the
latter  (except  to the extent that a Conflict of Interest exists) in connection
with  the  defense  thereof  other  than  reasonable costs of investigation.  No
Indemnifying  Party  shall  consent  to  entry of any judgment or enter into any
settlement, without the consent of the Indemnified Party, which does not include
as  an  unconditional  term  thereof, the giving by the claimant or plaintiff to
such  Indemnified Party of a release from all liability in respect to such claim
or  litigation.

<PAGE>

     (d)     Other  Indemnification.  Indemnification  similar to that specified
             ----------------------
in  the  preceding  subdivisions  of  this  Section  1.8  (with  appropriate
modifications)  shall  be  given  by  the Company and each Holder of Registrable
Securities  included  in any Registration Statement with respect to any required
registration or other qualification of securities under any Federal or state law
or  regulation  of  any  governmental  authority, other than the Securities Act.

     (e)     Indemnification  Payment.  The  indemnification  required  by  this
             ------------------------
Section  1.8 shall be made by periodic payments of the amount thereof during the
course  of  the  investigation  or  defense,  as  and when bills are received or
expense,  loss,  damage  or  liability  is  incurred.

     (f)     Survival  of  Obligations.  The obligations of the Company, Ziegler
             -------------------------
and  of  the  Holders  of  Registrable  Securities  under this Section 1.8 shall
survive  the  completion  of  any  offering of Registrable Securities under this
Agreement.

     (g)     Contribution.  If  the indemnification provided for in this Section
             ------------
1.8  is  unavailable or insufficient to hold harmless an Indemnified Party, then
each  Indemnifying  Party shall contribute to the amount paid or payable to such
Indemnified  Party  as  a  result  of the losses, claims, damages or liabilities
referred  to in this Section 1.8 an amount or additional amount, as the case may
be,  in  such  proportion as is appropriate to reflect the relative fault of the
Indemnifying  Party  or parties on the one hand and the Indemnified Party on the
other  in  connection  with  the  statements or omissions which resulted in such
losses,  claims,  demands or liabilities as well as any other relevant equitable
considerations.  The  relative  fault shall be determined by reference to, among
other  things, whether the untrue or alleged untrue statement of a material fact
or  the  omission  or  alleged  omission  to  state  a  material fact relates to
information supplied by the Indemnifying Party or parties on the one hand or the
Indemnified  Party  on  the  other and the parties' relative, intent, knowledge,
access  to  information  and  opportunity  to  correct  or  prevent  such untrue
statement  or omission.  Notwithstanding the foregoing, no Holder of Registrable
Securities  who  is  an  Indemnifying Party shall be obligated to contribute any
amount  pursuant  to  this  Section  1.8(g)  to the extent that the amount to be
contributed,  when  taken  together  with  amounts  payable by such Holder under
Section  1.8(b),  would exceed the net proceeds received by such Holder upon the
sale  of  the  Registrable  Securities  sold  in  the  offering  covered by such
registration.  The  amount  paid  to  an  Indemnified  Party  as a result of the
losses, claims, damages or liabilities referred to in the first sentence of this
Section  1.8(g) shall include any legal or other expenses reasonably incurred by
such  Indemnified Party in connection with investigating or defending any action
or  claim  which  is  the  subject  of  this  Section

     (h)     Excluded  Persons.     No  person  guilty  of  fraudulent
             -----------------
misrepresentation  within  the  meaning  of  Section 11(f) of the Securities Act
             -
shall  be  entitled  to  contribution from any Person who was not guilty of such
fraudulent  misrepresentation.

1.9     COVENANTS  RELATING  TO  RULE  144.

     With  a  view  to  making  available  the  benefits  of  certain  rules and
regulations  of  the  Commission  which  may  at  any  time  permit  the sale of
securities  of the Company to the public without registration after such time as
a  public market exists for the Common Stock of the Company, the Company agrees:

<PAGE>

     (a)     to  make  and keep public information available, as those terms are
understood  and defined in Rule 144 under the Securities Act, at all times after
the  effective  date of the first registration under the Securities Act filed by
the  Company  for  an  offering  of  its  securities  to  the  general  public;

     (b)     to  use  its  best  efforts  to  then file with the Commission in a
timely  manner all reports and other documents required of the Company under the
Securities Act and the Exchange Act, as amended (at any time after it has become
subject  to  such  reporting  requirements);  and

     (c)     so  long  as  the  Warrant is outstanding or Ziegler owns shares of
Common  Stock,  to furnish to Ziegler forthwith upon request a written statement
by the Company as to its compliance with the reporting requirements of said Rule
144  (at  any  time after ninety (90) days after the effective date of the first
Registration Statement filed by the Company for an offering of its securities to
the general public), and of the Securities Act and the Exchange Act (at any time
after  it  has become subject to such reporting requirements) a copy of the most
recent  annual  or  quarterly  report of the Company, and such other reports and
documents of the Company as Ziegler may reasonably request in availing itself of
any  rule  or  regulation  of  the Commission allowing a Holder to sell any such
securities  without  registration.

1.10     "MARKET  STAND-OFF"  AGREEMENT.

     (a)     Ziegler hereby agrees that, during the period of duration specified
by  the  managing  underwriter  of  Common  Stock  of  the Company, prior to and
following  the  effective  date of a registration statement of the Company filed
under  the  Act,  it  shall not, to the extent requested by the Company and such
underwriter,  directly  or  indirectly  sell,  offer  to  sell, contract to sell
(including, without limitation, any short sale), grant any option to purchase or
otherwise transfer or dispose of (other than to donees who agree to be similarly
bound)  any  securities of the Company held by it at any time during such period
except  Common  Stock  included  in  such registration; provided, however, that:

     (i)     in  the  case  of a Company-initiated registration, the Company, to
the  extent it is not proposing to sell shares during any such underwriting, all
directors  and  officers  of the Company, Holders of one percent (1%) or more of
the  Company's Common Stock on a fully diluted basis, and all other persons with
registrations  rights  with  respect  the  Company's  securities (whether or not
pursuant to this Agreement) shall enter into similar market-standoff agreements;

     (ii)     the  Company  shall require all future purchasers of the Company's
securities  prior  to  the  Company's initial public offering to execute similar
agreement;  and

     (iii)     such market stand-off time period shall not exceed seven (7) days
prior  to  and one hundred eighty (180) days following the effective date of the
registration  statement.

<PAGE>

     (b)     In  order  to  enforce  the covenant contained in Section 1.10, the
Company  may  impose  stop-transfer instructions with respect to the Registrable
Securities  of  each  Holder (and the shares or securities of every other person
subject  to  the  foregoing  restriction)  until  the  end  of  such  period.

     (c)     In  the event the Company waives any of its rights pursuant to this
Market-Standoff  Agreement  with respect to any shares of Common Stock or Common
Stock Equivalents (the "RELEASED SHARES"), Ziegler shall be deemed released from
its  obligations  under  this  Market-Standoff  Agreement  with  respect  to the
Released  Shares  to the extent of the number of Released Shares multiplied by a
fraction,  the numerator of which shall equal the number of Fully-Diluted Shares
held  and  issuable  to  Ziegler,  and  the denominator of which shall equal the
number  of  all  Fully  Diluted  Shares.

     (d)     In  the event that the Company receives a request for the filing of
a  registration  statement  of  the  Company  pursuant  to  Section  1.2 of this
Agreement,  and  the  Company does not exercise its rights under Section 1.2(b),
then the Company shall not, during the period specified by Ziegler, prior to and
following  the  effective  date  of  such  registration statement, to the extent
requested  by  Ziegler,  directly or indirectly sell, offer to sell, contract to
sell  (including,  without  limitation,  any  short  sale),  grant any option to
purchase  or  otherwise  transfer or dispose of any securities of the Company at
any  time  during such period except Common Stock included in such registration;
provided, however, that such market stand-off time period shall not exceed seven
(7) days prior to and one hundred eighty (180) days following the effective date
of the registration statement.  The Company shall use its best efforts to ensure
that  all directors and officers of the Company, and all Holders (whether or not
such  Holders are participating in the registration), and all other persons with
registration  rights  with  respect  the  Company's  securities  (whether or not
pursuant to this Agreement) enter into similar market-standoff agreements during
such  period.

1.11     TERMINATION  OF  REGISTRATION  RIGHTS.

     Ziegler  shall  not  be entitled to exercise any right provided for in this
Article  1  after  ten  (10)  years  following  the  Effective  Date.

1.12     NO  ADDITIONAL  RIGHTS.

     Nothing  contained  herein  shall  be deemed as granting to the Holders any
registration  rights  to which they are not entitled to as of the Effective Date
of  this  Agreement.  Any  reference  to  the  rights  of  Holders  to  obtain
registration  of  shares held by such Holder shall be determined by reference to
any agreement in existence as of the Effective date; provided, however, that any
such  agreement  shall  be deemed modified by this Agreement to provide that any
such  pre-existing  rights  shall be subject and subordinate to Ziegler's rights
hereunder.

<PAGE>

                                    ARTICLE 2
                              ASSIGNMENT OF RIGHTS

2.1     TRANSFERABILITY  OF  RIGHTS.

     Subject to the limitations set forth below, the registration rights granted
herein  may  be assigned (but only with all related obligations) by Ziegler to a
transferee  or  assignee  who, after such assignment or transfer, holds at least
100,000  shares  of Registrable Securities and who agrees in writing to be bound
by  all  of  the  terms  and  provisions  of  this  Agreement,  provided:

     (a)     the  Company  is,  within  a  reasonable  time after such transfer,
furnished  with  written  notice  of  the name and address of such transferee or
assignee  and  the securities with respect to which such registration rights are
being  assigned;

     (b)     such  transferee  or  assignee  agrees in writing to be bound by an
subject  to  the  terms  and  conditions  of  this  Agreement, including without
limitation  the  provisions  of  Section  1.10  above;

     (c)     such  assignment  shall  be effective only if immediately following
such  transfer  the  further disposition of such securities by the transferee or
assignee  is  restricted  under  the  Securities  Act;  and

     (d)     such  transfer  or  assignment of rights hereunder to an affiliate,
partner or member of a Holder will be without restriction as to number of shares
of  Registrable  Securities  transferred.

2.2     NUMBER  OF  SHARES  OF  TRANSFEREE.

     For  the  purposes  of  determining  the  number  of  shares of Registrable
Securities  held  by  a  transferee or assignee, the holdings of transferees and
assignees  of  a  partnership  who  are  partners  or  retired  partners of such
partnership (including spouses and ancestors, lineal descendants and siblings or
such  partners  or  spouses  who acquire Registrable Securities by gift, will or
intestate  succession) shall be aggregated together; provided that all assignees
and  transferees  who  would  not  qualify  individually  for  assignment  of
registration  rights  shall  have  a single attorney-in-fact for the purposes of
exercising any rights, receiving notices or taking any action under this Article
2.

                                    ARTICLE 3
                          OBSERVATION AND VOTING RIGHTS

3.1     OBSERVATION  RIGHTS.

          So  long  as  the  Loan  or  any other obligation to Ziegler under the
Transaction  Agreements remains outstanding, Ziegler shall have full observation
rights  for two representatives to attend all meetings of the Board of Directors
of Company, Executive Committee, Audit Committee, and Finance Committee, if any,
or  any other committee which has the authority to act for and bind the Company.
Company  shall  reimburse  Lender for travel expenses incurred for attendance at
all  such  meetings.  In lieu of physical presence at such meeting, the meetings
may be conducted by conference telephone equipment in which all parties may hear
each  other.  During  this  same  period,  the  Company  shall take no action by
unanimous written consent of its Board of Directors or unanimous written consent
of  its  shareholders  (or majority written consent if authorized to act in such
manner)  without  first providing notice of such action to Ziegler.  The Company
shall  give  such  representative  copies of all notices, minutes, consents, and
other  material  that  it  provides  to  its directors.  Such representative may
participate  in  discussions  of  matters  brought  to  the  Board.

<PAGE>

3.2     RIGHT  TO  BOARD  REPRESENTATION  UPON  AN  EVENT  OF  DEFAULT.

     Immediately  upon  the occurrence of an Event of Default, as defined in the
Transaction  Agreements,  Ziegler  shall have the right to immediately elect (or
otherwise have serve as) a majority of the Board of Directors and to continue to
elect  (or  serve  as) a majority of the Board of Directors until the earlier of
such  time  as  the  Event  of  Default  is  cured  or  such time as all amounts
outstanding  under  the  Loan have been paid.  In accordance with the rights set
forth  in  this  Section  3.2, immediately after the occurrence of such Event of
Default:

     (a)     the  Company  shall  immediately  cause  the  size  of the Board of
Directors  to be increased to a number of directors such the number of vacancies
created  by  such  increase constitutes a majority of the Board of Directors and
shall  then  cause persons designated by Ziegler to be appointed as directors to
fill  such  newly  created  vacancies  on  the  Board  of  Directors;  and

     (b)     the  Holders hereby agree to vote their shares of voting stock, and
take  such  other actions as shall be necessary for Ziegler's representatives to
constitute  a  majority  of  to  Board  of  Directors  in  accordance  with this
provision,  and  to  refrain  from  taking  any other action that conflicts with
Ziegler's  rights  hereunder.

3.3     RIGHT  TO  CONSENT.

     So  long  as  there  is  any  amount  due and outstanding to Ziegler by the
Company,  the  Company  shall  not amend its Certificate of Incorporation and/or
Certificate  of  Designation to issue any class of securities that are senior to
the  Company's  Common  Stock,  without  the  prior  consent  of  Ziegler.

                                    ARTICLE 4
                                  MISCELLANEOUS

4.1     SPECIFIC  PERFORMANCE.

     The  parties hereto acknowledge that there may be no adequate remedy at law
if  any  party  fails  to perform any of its obligations hereunder and that each
party  may be irreparably harmed by any such failure, and accordingly agree that
each  party,  in addition to any other remedy to which it may be entitled at law
or  in  equity,  shall  be  entitled  to  compel  specific  performance  of  the
obligations of any other party under this Agreement in accordance with the terms
and  conditions  of  this  Agreement.

<PAGE>

4.2     LIMITATION  ON  SUBSEQUENT  REGISTRATION  RIGHTS.

     From  and  after the date of this Agreement, the Company shall not, without
the prior written consent of Ziegler grant to any Person any registration rights
equal  to  or  more  favorable  than  those  granted  herein  to  Ziegler.

4.3     GOVERNING  LAW.

     This  Agreement  shall  be construed in accordance with and governed by the
laws  of  the  State  of  New  Jersey (without giving effect to any conflicts or
choice  of  laws  provisions  which  would cause the application of the domestic
substantive  laws  of  any  other  jurisdiction).

4.4     HEADINGS.

     The  descriptive  headings  of  the several sections and paragraphs of this
Agreement  are  inserted  for  convenience only, and do not constitute a part of
this  Agreement and shall not affect in any way the meaning or interpretation of
this  Agreement.

4.5     NOTICES.

     All  demands, notices, requests, consents and other communications required
or  permitted  under  this Agreement shall be in writing and shall be personally
delivered  or sent by facsimile machine (with a confirmation copy sent by one of
the  other  methods  authorized  in  this  Section),  or by commercial overnight
delivery service (including FedEx but excluding the U.S. Postal Service), as set
forth  below:

     (a)     If  to  the  Company,  addressed  to:

                         Worldwide  Medical  Corporation
                         13  Spectrum  Pointe  Drive
                         Lake  Forest,  CA  92630
                         Attn:  Daniel  G.  McGuire
                                President, CEO and Co-Chairman of the  Board
                         Fax:   (      )

             with  a  copy  to:

                         The  Lebrecht  Group,  APLC
                         22342  Avenida  Empresa,  Suite  230
                         Rancho  Santa  Margarita,  CA  92688
                         Attn:  Brian  A.  Lebrecht,  Esq.
                         Facsimile  (949)  635-1244

<PAGE>

     (b)     If  to  Ziegler,  addressed  to:

                         Ziegler  Healthcare  Fund  I,  LP
                         c/o  Ziegler  Healthcare  Capital,  LLC
                         Executive  Center  No.  2
                         Third  Floor
                         1040  Broad  Street
                         Shrewsbury,  NJ  07702
                         Attn:  Eric  Smith
                         Fax:   (732)  578-0501

             With  a  copy  to:

                         Epstein  Becker  &  Green,  P.C.
                         1227  25th  Street,  N.W.
                         Suite  700
                         Washington,  D.C.  20037
                         Attn:  Robert  D.  Reif
                         Phone:  (202)  861-1829
                         Fax:  (202)  296-2882

     (c)      if  to the Holders, to their addresses contained in the records of
the  Company.

Notices  shall  be deemed given upon the earliest to occur of (i) receipt by the
party  to  whom  such  notice  is  directed,  if hand delivered; (ii) if sent by
facsimile machine, on the day (other than a Saturday, Sunday or legal holiday in
the  jurisdiction  to which such notice is directed) such notice is sent if sent
(as  evidenced  by  the  facsimile confirmed receipt) prior to 5:00 p.m. Eastern
Time  and,  if  sent  after  5:00  p.m.  Eastern  Time, on the day (other than a
Saturday,  Sunday  or  legal holiday in the jurisdiction to which such notice is
directed)  after  which  such notice is sent; or (iii) on the first business day
(other  than  a  Saturday,  Sunday or legal holiday in the jurisdiction to which
such  notice  is  directed)  following  the  day  the same is deposited with the
commercial  carrier  if  sent  by  commercial  overnight delivery service.  Each
party,  by  notice  duly  given  in accordance therewith may specify a different
address  for  the  giving  of  any  notice  hereunder.

<PAGE>

4.6     ENTIRE  AGREEMENT;  AMENDMENTS.

     This Agreement, the Transaction Agreements  and the other writings referred
to  herein  or  delivered  pursuant  hereto which form a part hereof contain the
entire  understanding  of  the parties with respect to its subject matter.  This
Agreement supersedes all prior agreements and understandings between the parties
with  respect  to  its  subject  matter (except for the Transaction Agreements).
This  Agreement  may be amended and the observance of any term of this Agreement
may  be  waived  (either  generally  or  in  a  particular  instance  and either
retroactively  or  prospectively)  only by a written instrument duly executed by
the  Company, Ziegler and those Holders holding at least a majority of the stock
represented  by  all  Holders. Each Holder at the time or thereafter outstanding
shall be bound by an amendment or waiver authorized by this Section 4.6, whether
or  not  any such Registrable Securities shall have been marked to indicate such
consent.

4.7     ASSIGNABILITY.

     This  Agreement  and all of the provisions hereof will be assigned, without
the  consent of the Company, by Ziegler or any Holder to, and shall inure to the
benefit  of, any purchaser, transferee or assignee of any Registrable Securities
held  by  Ziegler, but only if (i) the terms and conditions of Article 2 of this
Agreement have been met, (ii) such purchaser, transferee or assignee becomes the
holder  of  record of Registrable Securities, (iii) the Company receives written
notice  of  such  purchase,  transfer  or  assignment,  and (iv) such purchaser,
transferee  or  assignee  agrees  in  writing  to  be  bound  by this Agreement.

4.8     COUNTERPARTS.

     This  Agreement  may be executed in two or more counterparts, each of which
shall  be deemed an original, but all of which together shall constitute one and
the  same  instrument.

                  [Remainder of page intentionally left blank]

<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first  written  above.

                                               WORLDWIDE  MEDICAL  CORPORATION

                                               By:    /s/ Daniel G. McGuire
                                                      _____________________
                                               Name:  Daniel G. McGuire
                                               Title: President

                                               ZIEGLER  HEALTHCARE  FUND  I,  LP

                                               By:    /s Douglas A. Korey
                                                      __________________________
                                               Name:  Douglas A. Korey
                                               Title: Member

                                               HOLDERS OF REGISTRABLE SECURITIES

                                               See  attached  counterpart
                                               signature  pages

<PAGE>

                           COUNTERPART SIGNATURE PAGE
                               TO RIGHTS AGREEMENT
                   by and among Worldwide Medical Corporation
                          Ziegler Healthcare Fund I, LP
                     and the Holder whose name appears below

     By  execution of this Counterpart Signature Page, the undersigned agrees to
become  a  party  to  and  be  bound  by  the  terms  of  the  Rights Agreement.

                              By:     /s/ Daniel G. McGuire
                                      ______________________________
                                      Signature

                                      Daniel G. McGuire
                                      ______________________________
                                      Print  Name
                              Its:    President

<PAGE>

                                    EXHIBIT A
                                    ---------

                                     Holders
                                     -------

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00043-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00043-of-00352.parquet"}]]